Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.

Tumor control probability (TCP) model calculations may be used in a relative manner to evaluate and optimize three-dimensional (3-D) treatment plans. Using a mathematical model which makes a number of simplistic assumptions, TCPs can be estimated from a 3-D dose distribution of the tumor given the dose required for a 50% probability of tumor control (D50) and the normalized slope (gamma) of the sigmoid-shaped dose-response curve at D50. The purpose of this work was to derive D50 and gamma from our clinical experience using 3-D treatment planning to treat non-small cell lung cancer (NSCLC) patients. Our results suggest that for NSCLC patients, the dose to achieve significant probability of tumor control may be large (on the order of 84 Gy) for longer (> 30 months) local progression-free survival.

[1]  M Goitein,et al.  Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  T E Schultheiss,et al.  Models in radiotherapy: definition of decision criteria. , 1985, Medical physics.

[3]  E. Noordijk,et al.  Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .

[5]  M. Tubiana,et al.  An approach to the interpretation of clinical data on the tumour control probability-dose relationship. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  T E Schultheiss,et al.  Can modest escalations of dose be detected as increased tumor control? , 1992, International journal of radiation oncology, biology, physics.

[7]  P. Blitzer,et al.  Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. , 1993, International journal of radiation oncology, biology, physics.

[8]  M. Martel,et al.  Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis. , 1993, International journal of radiation oncology, biology, physics.

[9]  R Mohan,et al.  Clinically relevant optimization of 3-D conformal treatments. , 1992, Medical physics.

[10]  W. Curran,et al.  The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. , 1990, International journal of radiation oncology, biology, physics.

[11]  T. Bortfeld,et al.  The Use of Computers in Radiation Therapy , 2000, Springer Berlin Heidelberg.

[12]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[13]  D L McShan,et al.  Full integration of the beam's eye view concept into computerized treatment planning. , 1990, International journal of radiation oncology, biology, physics.

[14]  P Okunieff,et al.  Clinical implications of heterogeneity of tumor response to radiation therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  R. Gelber,et al.  Improved methodology for analyzing local and distant recurrence. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Graham,et al.  Radiation therapy alone for stage I non-small cell lung cancer. , 1993, International journal of radiation oncology, biology, physics.

[17]  A Brahme,et al.  Dosimetric precision requirements in radiation therapy. , 1984, Acta radiologica. Oncology.